Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink
Current and future status of JAK inhibitors - The Lancet
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
After 25 years of drug development, do we know JAK? | RMD Open
JAK inhibitors in dermatology: The promise of a new drug class. - Abstract - Europe PMC
皮膚科でのJAK阻害薬 | ひらぐん皮ふ科・アレルギー科
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis - Wood - 2022 - International Journal of Dermatology - Wiley Online Library
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies
Selective Janus kinase inhibitors come of age | Nature Reviews Rheumatology
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors - ScienceDirect
Cells | Free Full-Text | Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Frontiers | Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library
JAK inhibitors prevent JAK activation. The signaling cascade that... | Download Scientific Diagram
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery
JAK Inhibitor 瑞石生物医药有限公司
